deltatrials
Completed OBSERVATIONAL NCT03410706

Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China (XAPEC)

Xarelto® for Real Life Anticoagulation in Pulmonary Embolism (PE) in China

Sponsor: Bayer

Updated 48 times since 2018 Last updated: Dec 22, 2022 Started: Feb 1, 2018 Primary completion: Jul 29, 2021 Completion: Dec 24, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pulmonary Embolism and is currently completed. Bayer leads this study, which shows 48 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Jan 2023 · 11 months · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

48 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2023 — Jul 2024 [monthly]

    Completed

  4. Feb 2022 — Jan 2023 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  5. Jan 2022 — Feb 2022 [monthly]

    Active Not Recruiting

Show 43 earlier versions
  1. Dec 2021 — Jan 2022 [monthly]

    Active Not Recruiting

  2. Nov 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  3. Oct 2021 — Nov 2021 [monthly]

    Active Not Recruiting

  4. Sep 2021 — Oct 2021 [monthly]

    Active Not Recruiting

  5. Jun 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  6. May 2021 — Jun 2021 [monthly]

    Active Not Recruiting

  7. Apr 2021 — May 2021 [monthly]

    Active Not Recruiting

  8. Mar 2021 — Apr 2021 [monthly]

    Active Not Recruiting

  9. Feb 2021 — Mar 2021 [monthly]

    Active Not Recruiting

  10. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting

  11. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  12. Nov 2020 — Dec 2020 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  13. Oct 2020 — Nov 2020 [monthly]

    Recruiting

  14. Sep 2020 — Oct 2020 [monthly]

    Recruiting

  15. Aug 2020 — Sep 2020 [monthly]

    Recruiting

  16. Jul 2020 — Aug 2020 [monthly]

    Recruiting

  17. Jun 2020 — Jul 2020 [monthly]

    Recruiting

  18. May 2020 — Jun 2020 [monthly]

    Recruiting

  19. Apr 2020 — May 2020 [monthly]

    Recruiting

  20. Mar 2020 — Apr 2020 [monthly]

    Recruiting

  21. Jan 2020 — Mar 2020 [monthly]

    Recruiting

  22. Dec 2019 — Jan 2020 [monthly]

    Recruiting

  23. Nov 2019 — Dec 2019 [monthly]

    Recruiting

  24. Oct 2019 — Nov 2019 [monthly]

    Recruiting

  25. Sep 2019 — Oct 2019 [monthly]

    Recruiting

  26. Aug 2019 — Sep 2019 [monthly]

    Recruiting

  27. Jul 2019 — Aug 2019 [monthly]

    Recruiting

  28. Jun 2019 — Jul 2019 [monthly]

    Recruiting

  29. May 2019 — Jun 2019 [monthly]

    Recruiting

  30. Apr 2019 — May 2019 [monthly]

    Recruiting

  31. Mar 2019 — Apr 2019 [monthly]

    Recruiting

  32. Feb 2019 — Mar 2019 [monthly]

    Recruiting

  33. Jan 2019 — Feb 2019 [monthly]

    Recruiting

  34. Dec 2018 — Jan 2019 [monthly]

    Recruiting

  35. Nov 2018 — Dec 2018 [monthly]

    Recruiting

  36. Oct 2018 — Nov 2018 [monthly]

    Recruiting

  37. Sep 2018 — Oct 2018 [monthly]

    Recruiting

  38. Aug 2018 — Sep 2018 [monthly]

    Recruiting

  39. Jul 2018 — Aug 2018 [monthly]

    Recruiting

  40. Jun 2018 — Jul 2018 [monthly]

    Recruiting

  41. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NANone

  42. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  43. Feb 2018 — Mar 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
  • Janssen Research & Development, LLC
Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations